跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 372 条关于
“EP-104GI”
全部
372
临床试验
137
药物
147
机构
4
资讯
84
10个月前
Eupraxia's EP-104GI Shows Sustained Clinical Remission in Eosinophilic Esophagitis Patients at 52 Weeks
去年
Eupraxia's EP-104GI Shows Promising Results in Eosinophilic Esophagitis Trial
7个月前
Eupraxia Pharmaceuticals Raises $55 Million to Advance Eosinophilic Esophagitis Treatment
去年
EP-104IAR Shows Promise for Knee Osteoarthritis Pain Relief in Phase 2 Trial
去年
Medtronic's Affera System Receives FDA Approval for Atrial Fibrillation Treatment
去年
Leads Biolabs' LBL-024 Receives Breakthrough Therapy Designation in China for EP-NEC
去年
Stereotaxis' Magbot Magnetic Ablation Catheter Approved in China
去年
UPC Dismisses Sanofi's Infringement Claim Against Amgen's Repatha in Landmark PCSK9 Inhibitor Ruling
去年
Novel AAV Capsid Shows Unprecedented Brain Transduction Potential for Gene Therapy
上个月
EPO Boards of Appeal Revokes BMS Opdivo Patent, Clearing Path for Nivolumab Biosimilars
第 1 页,共 9 页
上一页
下一页